AERIE PHARMACEUTICALS INC Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2012 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Aerie Pharmaceuticals Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2012 to Q3 2022.
  • Aerie Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2022 was $3.64M, a 44.9% decline year-over-year.
  • Aerie Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2022 was $18.4M, a 44.2% decline year-over-year.
  • Aerie Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2021 was $29.5M, a 26.4% decline from 2020.
  • Aerie Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2020 was $40.1M, a 11.1% decline from 2019.
  • Aerie Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2019 was $45.1M, a 16.4% increase from 2018.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $18.4M $3.64M -$2.97M -44.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $21.4M $3.96M -$4.04M -50.5% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $25.4M $4.63M -$4.12M -47.1% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $29.5M $6.17M -$3.42M -35.7% Oct 1, 2021 Dec 31, 2021 10-K 2022-02-25
Q3 2021 $32.9M $6.61M -$3.19M -32.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $36.1M $8M -$2.18M -21.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $38.3M $8.75M -$1.78M -16.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $40.1M $9.59M -$1.58M -14.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-25
Q3 2020 $41.7M $9.8M -$806K -7.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $42.5M $10.2M -$519K -4.85% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $43M $10.5M -$2.09M -16.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $45.1M $11.2M +$1.46M +15% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $43.6M $10.6M +$628K +6.29% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $43M $10.7M +$377K +3.65% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $42.6M $12.6M +$3.9M +44.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $38.7M $9.71M +$1.71M +21.3% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $37M $9.98M +$3.42M +52.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $33.6M $10.3M +$3.65M +54.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $29.9M $8.72M +$3.87M +79.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $26.1M $8.01M +$2.73M +51.6% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 $23.4M $6.56M +$2.46M +60% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $20.9M $6.67M +$2.78M +71.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $18.1M $4.85M +$1.32M +37.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $16.8M $5.28M +$1.87M +54.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $14.9M $4.1M +$783K +23.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $14.1M $3.88M +$405K +11.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $13.7M $3.53M +$793K +28.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $12.9M $3.41M +$930K +37.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $12M $3.32M +$924K +38.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $11.1M $3.48M +$1.09M +45.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $10M $2.74M +$819K +42.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q4 2014 $9.18M $2.48M +$1.16M +87% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-09
Q3 2014 $8.02M $2.39M +$1.26M +112% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $6.76M $2.38M +$2.15M +905% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $4.62M $1.92M +$1.76M +1072% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $2.86M $1.33M Oct 1, 2013 Dec 31, 2013 10-K 2016-03-02
Q3 2013 $1.13M +$1.02M +946% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $237K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $164K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q3 2012 $108K Jul 1, 2012 Sep 30, 2012 10-Q 2013-12-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.